Valuation: PIOLAX, Inc.

Market Cap 41.11B 260M 225M 210M 193M 363M 24.8B 369M 2.45B 966M 12.43B 979M 957M P/E 2027 *
34.5x
P/E 2028 * 30.6x
Enterprise Value 46.12B 292M 253M 236M 217M 407M 27.82B 414M 2.75B 1.08B 13.94B 1.1B 1.07B EV / Sales 2027 *
0.73x
EV / Sales 2028 * 0.8x
Free-Float
44.2%
Yield 2027 *
5.4%
Yield 2028 * 5.4%
Manager TitleAgeSince
President 61 2024-05-31
Chief Administrative Officer - 2024-06-24
Chief Tech/Sci/R&D Officer 63 2016-05-31
Director TitleAgeSince
Chairman 68 2024-05-31
Director/Board Member 63 2020-08-04
Director/Board Member 63 2022-06-23
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 263M
-1.34%+0.95%+113.75%+391.66% 42.51B
+2.04%+14.44%+109.44%+219.13% 37.65B
-2.26%+11.57%+73.60%+115.87% 31.85B
+0.23%-12.20%-7.39%-20.74% 30.46B
-1.16%-7.36%-0.29%+45.22% 21.05B
+3.09%+0.13%+70.00%+20.19% 17.99B
+9.25%+14.73%+76.79%+161.10% 17.03B
+0.32%-5.22%-5.40%-4.29% 15.69B
+3.98%+6.23%+79.82%+60.91% 13.4B
Average +1.42%-0.30%+56.70%+109.89% 25.29B
Weighted average by Cap. +0.89%+0.38%+64.23%+143.94%

Financials

2027 *2028 *
Net sales 63B 399M 345M 322M 296M 556M 38B 565M 3.75B 1.48B 19.04B 1.5B 1.47B 65B 412M 356M 333M 305M 574M 39.21B 583M 3.87B 1.53B 19.65B 1.55B 1.51B
Net income 1.1B 6.97M 6.03M 5.63M 5.17M 9.71M 664M 9.86M 65.55M 25.85M 333M 26.18M 25.61M 1.24B 7.85M 6.8M 6.34M 5.82M 10.95M 748M 11.12M 73.89M 29.14M 375M 29.51M 28.87M
Net Debt 5B 31.69M 27.43M 25.6M 23.5M 44.17M 3.02B 44.86M 298M 118M 1.51B 119M 116M 10.76B 68.19M 59.02M 55.07M 50.56M 95.04M 6.49B 96.53M 641M 253M 3.25B 256M 251M
Logo PIOLAX, Inc.
Piolax Inc is a Japan-based company principally engaged in the manufacture and sale of automotive related products. The Company operates in two business segments. Automotive Related Business segment is mainly involved in the manufacture and sale of precision springs, industrial fasteners, as well as small unit parts that combine resin and metal to the automobile industry. Medical Equipment Business segment is involved in the manufacture and sale of interventional radiology (IVR), endoscopic treatment, and orthopedic treatment equipment to medical institutions.
Employees
2,784
Trader
Investor
Global
Quality
ESG MSCI
BB